ABT: Abbott Laboratories - Summary | Jitta

Abbott Laboratories

NYSE:ABT

Price
$83.42
Loss Chance
52.8%
4.63JITTA SCORE
54.15%Above Jitta Line
Jitta Ranking
135 / 816
1,847 / 4,762
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (23)
Recent Business Performance (50)
Financial Strength (30)
Return to Shareholders (25)
Competitive Advantage (54)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Revenue and EarningEarning decline from 2015-2018
Operating MarginInconsistent
Debt LevelHigh Long Term Debt
Key Stats
Jitta Score
Jitta Line
4.63
54.15%
2.24
0.66%
Healthcare Equipment
5.20
65.25%
8.10
29.53%
0.70
100.00%
COMPANY DESCRIPTION
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems for infectious diseases; molecular point-of-care care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The company’s Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company also provides glucose and blood glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.